SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-20-000018
Filing Date
2020-02-28
Accepted
2020-02-28 08:17:40
Documents
4
Effectiveness Date
2020-02-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A pdli-20200228defa14adoc.htm DEFA14A 47490
2 COOPERATION AGREEMENT pdli-20200228ex101.htm EX-10.1 155422
3 PRESS RELEASE pdli-20200228ex991.htm EX-99.1 19322
4 pdllogo2a09.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000018.txt   392765
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 20665725
SIC: 2836 Biological Products, (No Diagnostic Substances)